Drug research

Pociredir

Open a linked trial to see its study details and recorded changes, or check the regulatory events below and follow their sources.

Drug identity checked against registry records

Also recorded as FTX-6058

A drug appearing in a clinical trial does not mean it is FDA-approved. Check the original regulatory source for any approval claim.

Included trials

Trial	Sponsor	Phase	Status	Primary completion
Open-Label Extension Study to Pioneer Study 6058-SCD-101NCT07401823	Fulcrum Therapeutics	Phase 2	Enrolling by invitation	2030-02-04Estimated

Fulcrum TherapeuticsEnrolling by invitationPrimary completion: 2030-02-04 · Estimated

Trial details

No regulatory events match this view.Try another date range or view. Events appear after automated source checks. This does not mean no FDA events have occurred. Dates that a source does not disclose stay undisclosed.